BikowskiJB. Molluscum contagiosum: The need for physician intervention and new treatment options. Cutis2004;73:202–6.
2.
SyedTALundinSAhmadM. Topical 0.3% and 0.5% podophyllotoxin cream for self-treatment of molluscum contagiosum in males. A placebo-controlled, double-blind study. Dermatology1994;189:65–8.
3.
RossGLOrchardDC. Combination topical treatment of molluscum contagiosum with cantharidin and imiquimod 5% in children: A case series of 16 patients. Australas J Dermatol2004;45:100–2.
4.
HenggeUREsserSSchultewolterT. Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol2000;143:1026–31.
5.
SyedTAGoswamiJAhmadpourOAAhmadSA. Treatment of molluscum contagiosum in males with an analogue of imiquimod 1% in cream: A placebo-controlled, double-blind study. J Dermatol1998;25:309–13.
6.
BrownCWO'DonoghueMMooreJTharpM. Recalcitrant molluscum contagiosum in an HIV-afflicted male treated successfully with topical imiquimod. Cutis2000;65:363–6.
7.
SkinnerRB. Treatment of molluscum contagiosum with imiquimod 5% cream. J Am Acad Dermatol2002;47(4 Suppl):S221–4.
8.
PorterCDArchardLC. Characterization and physical mapping of molluscum contagiosum virus DNA and location of a sequence capable of encoding a conserved domain of epidermal growth factor. J Gen Virol1987;68:673–82.
9.
WallEMGaoJXUptonC. Subversion of cytokine networks by viruses. Int Rev Immunol1998;17:121–55.
10.
AlcamiAKoszinowskiUH. Viral mechanisms of immune evasion. Immunol Today2000;21:447–55.
